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Liver cysts in Congolese patients with autosomal dominant 
polycystic kidney disease follow a family pattern 
A G H Assounga, Y Yacoubou, E Makosso, J R lbara, T Gombet 
Background. It is now well established that at least two genes 
are associated with autosomal dominant polycystic kidney 
disease (ADPKD). 
Objective. To analyse the clinical expression of ADPKD in 
Congolese patients and to compare ADPKD expression 
between families. 
Methods. Following informed consent, ADPKD patients 
admitted to Brazzaville University Hospital (Congo) were 
reviewed and their relatives aged 20 years and older were 
screened by means of a clinical examination, abdominal 
ultrasound, urinalysis and determination of serum creatinine. 
Results. We found 7 patients with ADPKD, belonging to 7 
Autosomal dominant polycystic kidney disease (ADPKD), a 
common hereditary disease worldwide, is not well 
documented in Africa, with only a few reports available.1-3 
ADPKD is one of the most frequently inherited disorders, with 
a prevalence ranging from 1 I 400 to 1/1 000 in Europe and 
America! Much progress has been made in characterising the 
genes involved and their products. ADPKD is characterised by 
an adult clinical onset, the presence of at least three kidney 
cysts bilaterally, and an autosomal dominant transmission! 
ADPKD is reported to be associated with at least two genes. 
The PKDl gene is located on chromosome 16p3.3, and the 
PKD2 gene on chromosome 4q21-23.57 Their products are 
membrane-bound proteins that are expressed in most epithelial 
tissue and the brain.' They interact and function as hetero-
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distinct families, and identified 100 relatives of whom 50, 
aged from 20 to 68 years, were diagnosed as having ADPKD. 
Polycystic kidney disease was associated with polycystic liver 
in 4 families. In the remaining 3 families no liver cysts were 
found. No family had a mixture of members with kidney 
cysts only and members with kidney and liver cysts. This 
finding was age-independent. 
Conclusion. Liver cysts follow a family pattern in our ADPKD 
patients. We suggest that our patients may carry at least two 
different genes for ADPKD, one of which may be associated 
with renal cysts alone and other with both renal and liver cysts. 
S Afr Med J 2003; 93: 542-544. 
dimers. Patients with ADPKD have higher expression of both 
alleles, raising the question whether PKD1 is the triggering 
factor for cyst formation or whether it is a secondary factor. It 
has been associated with the maturation and repair of the renal 
tubule. The PKD1 gene is associated with early and severe 
symptoms, while PKD2 and other genes are associated with 
late and less severe symptoms.' In light of the diversity of 
genes involved we examined the expression of ADPKD in 
Congolese patients. The objective of this study was to analyse 
the clinical features of ADPKD in patients admitted to the 
Department of Nephrology and Haemodialysis at Brazzaville 
University Hospital from December 1989 to February 1995, as 
well as the clinical features of their respective family members. 
Materials and methods 
All patients admitted to the Department of Nephrology and 
Haemodialysis from December 1989 to March 1994 who had at 
least three cysts in each kidney on abdominal ultrasonography, 
were at least 20 years old, and had a family history suggestive 
of hereditary disease were included. Patients were excluded if 
there was no family history of polycystic kidney disease or if 
renal cysts were absent in relatives. Patients who developed 
renal cysts after a long period of dialysis were also excluded. 
Seven patients were identified. 
After giving informed consent, relatives of patients 
underwent a clinical examination, a serum creatinine test, 
urinalysis, an abdominal ultrasound scan, and monthly follow-
up for 6 months if found to have polycystic kidney disease. 
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The chi-square test or Fisher's exact test was used to 
compare different groups, using the Instat 2 software program 
(GraphPad Instat, San Diego, Calif., USA). 
Results 
We found that the patients who fulfilled the criteria for 
ADPKD belonged to 7 distinct families. Of 100 relatives of 
patients screened, 50 were found to have ADPKD. The total 
number of patients with ADPKD was therefore 57 (7 
symptomatic and 50 asymptomatic). Ages ranged from 25 to 68 
years. There were 34 men and 23 women. 
Clinical features are summarised in Table I (Figs I and 2). 
Clinical symptoms and signs seemed more severe in the 4 
families with associated liver cysts, but the difference was not 
statistically significant (p > 0.05), except for the presence of anal 
fistula (p = 0.0012). A high prevalence of anal fistula was found 
in one of the families with polycystic liver and kidney disease; 
no colonoscopy was done to search for diverticulitis. No 
pancreatic cysts or other organ cysts were found. No search for 
cerebral aneurysm was carried out. The pattern of organ 
involvement was similar in patients within the same family. 
Polycystic kidney disease was associated with polycystic liver 
in 4 families. In the remaining 3 families, no liver cysts were 
found. No family included a mixture of patients with kidney 
cysts only and patients with kidney and liver cysts. This 
finding was age-independent. In families with ADPKD where I 
member had hepatic cysts all the relatives with kidney cysts 
also had hepatic cysts (Fig. 3). The presence or absence of 
hepatic cyst follows a family pattern (Figs 3 and 4). All families 
ran true to form, showing either renal cysts alone or both renal 
and liver cysts, but never a combination of both patterns 
within a single family. 
Discussion 
ADPKD is prevalent in the Congo and its clinical expression 
mirrors that described elsewhere. The pattern of clinical 
manifestation suggests that more than one gene is involved. In 
4 of 7 families, kidney cysts were associated with liver cysts. 
The association of liver cysts with kidney cysts is thought to be 
a poor prognostic factor.' In our study, patients with only 
kidney cysts seemed to have less severe manifestations than 
those with both kidney and liver cysts; however the difference 
was not statistically significant. Clinical manifestations in our 
ADPKD patients were similar to those described elsewhere. 1-4 
However, the incidence of ADPKD is lower than in Europe or 
the USA. A lower incidence of ADPKD has been reported in 
black Americans compared with whites.' Clinical expression is 
characterised by low back pain, abdominal mass and 
haematuria as main complaints leading to the diagnosis of 
ADPKD. Hypertension was found in 7% of our patients. 
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Table I. Clinical manifestations of ADPKD according to 
presence or absence of liver cysts 
ADPKD ADPKD 
patients patients 
with liver without 
Clinical cysts liver cysts Total 
manifestations N % N % N% 
Number of families 4 57 3 43 7 100 
Number of patients 37 65 20 35 57 100 
Hypertension 5 13.5 2 IO 7 12.3 (p > 0.05) 
Renal failure 6 I6.2 2 IO 8 I4 (p > 0.05) 
Abdominal pain 4 11 3 15 7 12 
Macroscopic haematuria 7 19 4 19 11 19.3 
Urinary tract infection 4 10.8 3 15 7 12.3 
Stroke 2.7 0 0 1 1.8 
Anal fistula 20 25 0 0 20 35 (p = 0.0012) 
Fig. 1. Ultrasound scan of a kidney showing multiple cysts. 
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Fig. 3. Pedigree of a family with patients with both multiple renal 
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Fig. 4. Pedigree of a family with patients with multiple cysts only in 
the kidney. 
During the same period the prevalence of hypertension among 
inpatients was 9.46%. Chronic renal failure (CRF) was present 
in 7% of our patients. ADPKD represents 2% of patients with 
CRF. Development of liver cysts in ADPKD has been associat.ed 
with female gender, pregnancy; age, and severity of renal 
disease.' 
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ADPKD genes are widely expressed. Polycystin 1 and 
polycystin 2 have been found in all major organs, including the 
liver and kidney. The highest expression of polycystin has been 
found in the brain. The kidney has an intermediate level 
expression of polycystin. In normal individuals, polycystin is 
found in the cytoplasm and is markedly present in the lateral 
junction of epithelial cells of the distal tubule in the normal 
kidney, and of the proximal tubule in the injured kidney. In 
patients with ADPKD there is an over-expression of polycystin 
1 and polycystin 2 compared with normal controls. Polycystin 
is expressed with variable intensity in the epithelial lining of 
both renal and liver cysts and is more intense in the cytoplasm 
than in the lateral membrane.5•7 
The progression of ADPKD is dependent of four groups of 
factors: the germline mutation (PKDl or PKD2 gene), the 
modifying genes, the somatic mutations, and environment 
factors. 10 Several mutations of the PKDl and PKD2 genes have 
been reported in patients with ADPKD. A mutation in either 
the PKDl and PKD2 gene that affects the interaction of 
polycystin 1 and polycystin 2 is believed to be responsible for 
the cyst formation. 10 A defect in both copies of PKDl genes is 
required for a defunct polycystin. The resulting defect in fluid 
movement and epithelial distribution will alter the normal 
architecture leading to cyst formation. Environmental factors 
the progression of cysts include endotoxins and acidifying 
agents, which accelerate cyst progression in mice, whereas 
alkalising agents and a low-protein diet slow progression.10 
To our knowledge, although the association of liver cysts 
with ADPKD is well established in individual patients, this is 
the first report indicating that the presence of liver cysts in 
ADPKD follows a family pattern. We suggest that our patients 
may carry at least two different genes for ADPKD, one of 
which may be associated with renal cysts alone, and the other 
with both renal and liver cysts. A genetic analysis is warranted 
in order to determine whether PKD1, PKD2 or other genes are 
involved in our patients. 
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